No OS Boost With Opdivo in Recurrent Glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 22, 2020 Category: Cancer & Oncology Source Type: clinical trials

Brain Tumor Webinar Series Continues
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 22, 2020 Category: Cancer & Oncology Source Type: clinical trials

Novel Immunotherapy Approach Holds Promise for Pediatric Brain Cancer
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 20, 2020 Category: Cancer & Oncology Source Type: clinical trials

Hoag is First in Nation to Test Innovative Antibody Brain Cancer Drug
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 20, 2020 Category: Cancer & Oncology Source Type: clinical trials

Novel Immunotherapy Approach Holds Promise for Pediatric Brain Cancer
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 20, 2020 Category: Cancer & Oncology Source Type: clinical trials

Hoag is First in Nation to Test Innovative Antibody Brain Cancer Drug
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 20, 2020 Category: Cancer & Oncology Source Type: clinical trials

Musella Foundation Brain Tumor Awareness Month Webinar Series
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 18, 2020 Category: Cancer & Oncology Source Type: clinical trials

Brain Tumor Awareness Monthly Webinar Series video posted: Advances in neuro-imaging
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 16, 2020 Category: Cancer & Oncology Source Type: clinical trials

Musella Foundation Webinar Series: A Promising New Radiotherapy for Recurrent Glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 16, 2020 Category: Cancer & Oncology Source Type: clinical trials

Brain Tumor Awareness Monthly Webinar Series video posted: Advances in neuro-imaging
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 16, 2020 Category: Cancer & Oncology Source Type: clinical trials

Musella Foundation Webinar Series: A Promising New Radiotherapy for Recurrent Glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 16, 2020 Category: Cancer & Oncology Source Type: clinical trials

Brain Tumor Awareness Monthly Webinar Series video posted: Advances in neuro-imaging
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 16, 2020 Category: Cancer & Oncology Source Type: clinical trials

Musella Foundation Webinar Series: A Promising New Radiotherapy for Recurrent Glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 16, 2020 Category: Cancer & Oncology Source Type: clinical trials

Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 14, 2020 Category: Cancer & Oncology Source Type: clinical trials

China NMPA Approves Optune ® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 14, 2020 Category: Cancer & Oncology Source Type: clinical trials

Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 14, 2020 Category: Cancer & Oncology Source Type: clinical trials

China NMPA Approves Optune ® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 14, 2020 Category: Cancer & Oncology Source Type: clinical trials

Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 14, 2020 Category: Cancer & Oncology Source Type: clinical trials

China NMPA Approves Optune ® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 14, 2020 Category: Cancer & Oncology Source Type: clinical trials

Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 14, 2020 Category: Cancer & Oncology Source Type: clinical trials

China NMPA Approves Optune ® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 14, 2020 Category: Cancer & Oncology Source Type: clinical trials

Brain Tumor Awareness MonthWebinar Series - Advances in neuro-imaging
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 10, 2020 Category: Cancer & Oncology Source Type: clinical trials

Improved Survival for GBM Patients Treated with DC Vaccine and Adjuvant TLR-3 Agonist in Phase II Clinical Trial
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 6, 2020 Category: Cancer & Oncology Source Type: clinical trials

Diverse Biotech announces orphan-drug designation for treatment of newly diagnosed glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 6, 2020 Category: Cancer & Oncology Source Type: clinical trials

Improved Survival for GBM Patients Treated with DC Vaccine and Adjuvant TLR-3 Agonist in Phase II Clinical Trial
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 6, 2020 Category: Cancer & Oncology Source Type: clinical trials

Diverse Biotech announces orphan-drug designation for treatment of newly diagnosed glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 6, 2020 Category: Cancer & Oncology Source Type: clinical trials

Improved Survival for GBM Patients Treated with DC Vaccine and Adjuvant TLR-3 Agonist in Phase II Clinical Trial
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 6, 2020 Category: Cancer & Oncology Source Type: clinical trials

Diverse Biotech announces orphan-drug designation for treatment of newly diagnosed glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 6, 2020 Category: Cancer & Oncology Source Type: clinical trials

Improved Survival for GBM Patients Treated with DC Vaccine and Adjuvant TLR-3 Agonist in Phase II Clinical Trial
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 6, 2020 Category: Cancer & Oncology Source Type: clinical trials

Diverse Biotech announces orphan-drug designation for treatment of newly diagnosed glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 6, 2020 Category: Cancer & Oncology Source Type: clinical trials

Improved Survival for GBM Patients Treated with DC Vaccine and Adjuvant TLR-3 Agonist in Phase II Clinical Trial
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 6, 2020 Category: Cancer & Oncology Source Type: clinical trials

Diverse Biotech announces orphan-drug designation for treatment of newly diagnosed glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 6, 2020 Category: Cancer & Oncology Source Type: clinical trials

Improved Survival for GBM Patients Treated with DC Vaccine and Adjuvant TLR-3 Agonist in Phase II Clinical Trial
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 6, 2020 Category: Cancer & Oncology Source Type: clinical trials

Diverse Biotech announces orphan-drug designation for treatment of newly diagnosed glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 6, 2020 Category: Cancer & Oncology Source Type: clinical trials

Brain Tumor Awareness Month Seminar Series continues tonight at 7pm eastern time
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 3, 2020 Category: Cancer & Oncology Source Type: clinical trials

Unique greeting cards take on new meaning in the era of covid-19
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 1, 2020 Category: Cancer & Oncology Source Type: clinical trials

Pharmacokinetics, Safety and Tolerability of Olaparib and Temozolomide for Recurrent Glioblastoma: Results of the Phase I OPARATIC Trial
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 1, 2020 Category: Cancer & Oncology Source Type: clinical trials

Having sold its corporate self, Tocagen auctions off scientific platform to San Diego biotech
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - May 1, 2020 Category: Cancer & Oncology Source Type: clinical trials